Last Updated: November 8, 2026

Pharmacia Company Profile

« Back to Dashboard


What is the competitive landscape for PHARMACIA

PHARMACIA has seventy-three approved drugs.



Summary for Pharmacia
US Patents:0
Tradenames:60
Ingredients:58
NDAs:73
Patent Litigation for Pharmacia: See patent lawsuits for Pharmacia

Drugs and US Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn CORTEF hydrocortisone cypionate SUSPENSION;ORAL 009900-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn MEDROL methylprednisolone acetate ENEMA;RECTAL 018102-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn CALMURID HC hydrocortisone; urea CREAM;TOPICAL 083947-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn NEO-CORTEF hydrocortisone acetate; neomycin sulfate SUSPENSION/DROPS;OPHTHALMIC 060612-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn NORMIFLO ardeparin sodium INJECTABLE;INJECTION 020227-002 May 23, 1997 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Pharmacia And Upjohn DELTASONE prednisone TABLET;ORAL 009986-008 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Pharmacia

Paragraph IV (Patent) Challenges for PHARMACIA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 5 mg/80 mg ➤ Subscribe 2009-04-07
➤ Subscribe Tablets 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 10 mg/10 mg, 10 mg/20 mg and 10 mg/80 mg ➤ Subscribe 2006-12-29
➤ Subscribe Tablets 2.5 mg/40 mg ➤ Subscribe 2009-09-17
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.